10.64
+0.08(+0.76%)
Currency In USD
| Previous Close | 10.56 |
| Open | 10.35 |
| Day High | 10.95 |
| Day Low | 10.35 |
| 52-Week High | 14.39 |
| 52-Week Low | 3.96 |
| Volume | 1.41M |
| Average Volume | 1.79M |
| Market Cap | 1.36B |
| PE | -28.76 |
| EPS | -0.37 |
| Moving Average 50 Days | 11.75 |
| Moving Average 200 Days | 9.07 |
| Change | 0.08 |
If you invested $1000 in Trevi Therapeutics, Inc. (TRVI) since IPO date, it would be worth $1,348.54 as of February 21, 2026 at a share price of $10.64. Whereas If you bought $1000 worth of Trevi Therapeutics, Inc. (TRVI) shares 5 years ago, it would be worth $3,558.53 as of February 21, 2026 at a share price of $10.64.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Trevi Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
GlobeNewswire Inc.
Feb 17, 2026 12:30 PM GMT
Fireside chat with management on February 25, 2026, at 9:20 a.m. ETNEW HAVEN, Conn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvi